BETHANY BROWN: Open Payments
NPI 1366848798 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $324 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: DEXCOM G7 GSS (161), TREMFYA, JARDIANCE, UBRELVY, ROTATEQ, Ozempic, SPRAVATO.
Industry payments across OK — which companies pay providers there.
